ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3176

New Prospects for Interpreting Bony Depressions in Juvenile Idiopathic Arthritis: A Novel MRI Computer-Assisted Technique for Detection of Erosive Progression

Pieter van Dijkhuizen1,2, Carlotta Covizzi1, Andrea Schiappacasse3, Michela Moraldo4, Matteo Santoro5, Francesca Magnaguagno6, Gianmichele Magnano7, Alberto Martini1,4 and Clara Malattia1,4, 1Istituto G Gaslini, Pediatria II, Reumatologia, Genova, Italy, 2UMC Utrecht, Wilhelmina Children’s Hospital, Pediatric rheumatology, Utrecht, Netherlands, 3DIBRIS Università degli studi di Genova, Genova, Italy, 4DINOGMI Università degli studi di Genova, Genova, Italy, 5Camelot Biomedical Systems, Genova, Italy, 6Istituto G Gaslini, UO Radiologia Pediatrica, Genoa, Italy, 7Istituto G Gaslini, UO Radiologia Pediatrica, Genova, Italy

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Bone, Diagnostic imaging, juvenile idiopathic arthritis (JIA) and magnetic resonance imaging (MRI)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects IV: Imaging and Novel Clinical Interventions

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Structural damage is the main disease outcome to be avoided in JIA. The gold standard to assess joint damage in JIA is X-ray, which is however limited by its late detection of erosions. Alternatively, MRI is sensitive, but distinction between normal variants and bone erosions secondary to the disease is a real challenge. We posit that only bony depressions whose size increases over time should be considered true bone erosions. To test this hypothesis, we developed software to co-register and compare baseline and follow-up MRIs. The aim of this study was to assess the performance of this novel method in detecting bone erosion progression.

Methods: 66 JIA patients with active wrist arthritis who participated in a prospective trial, were enrolled. The baseline and 1 year follow-up MRI of the wrists were assessed separately according to the OMERACT RAMRIS score. Erosive progression was defined as a change between the baseline and 1-year follow-up MRI bone erosion score of at least two points. The novel computer-assisted MRI technique allows to visualize simultaneously two consecutive MRIs and to overlap each of the carpal bones, distal radius, distal ulna and metacarpal bones. Two independent readers assigned 0 or 1 points to each bone indicating absence or presence of progression, respectively. Structural damage progression was defined as progression in at least one bone. The baseline and last X-ray available for each patient were scored according to the Sharp-Van der Heijde method with a difference of at least 2 points indicating joint damage progression. This score served as reference standard for the MRI scores. Inter-reader reliability of the new method was assessed by Cohen’s kappa. Of both MRI scores, the diagnostic properties and correlation with clinical variables were evaluated.

Results: Median disease duration at baseline was 4.9 years. The last X-ray was available in 43 patients after a median time of 4.2 years from baseline. 23 (35%) patients showed radiographic progression of joint damage, while 14 (21%) and 32 (48%) patients showed progression of bone erosions using the RAMRIS score and computer-assisted technique, respectively. Inter-reader agreement for detecting erosive progression using the novel software was substantial, with Cohen’s kappa ranging from 0.63-1 for the individual bones and equaling 0.79 for the total score. The novel method was accurate with a sensitivity of 0.83, specificity of 0.78, positive predictive value (PPV) of 0.83 and negative predictive value (NPV) of 0.78, whereas the RAMRIS bone erosion score performed poorly with a sensitivity of 0.17, specificity of 0.74, PPV of 0.44 and NPV of 0.42. As expected, the novel method did not correlate with traditional measurements of disease activity, while it was correlated with validated measurements of damage such as conventional radiography (Spearman’s rho = 0.60).

Conclusion: The novel method outperformed the RAMRIS bone erosion score and allowed a reliable and accurate evaluation of structural damage progression in JIA, with the potential to select patients who are eligible for a more aggressive treatment.


Disclosure: P. van Dijkhuizen, None; C. Covizzi, None; A. Schiappacasse, None; M. Moraldo, None; M. Santoro, None; F. Magnaguagno, None; G. Magnano, None; A. Martini, AbbVie Inc., AstraZeneca, Bristol-Myers Squibb, Janssen Biologics B.V., Eli Lilly and Co., "Francesco Angelini", GlaxoSmithKline, Italfarmaco, Novartis, Pfizer, Roche, Sanofi Aventis, Schwarz Biosciences GmbH, Xoma, Astellas, medImmune and Wyeth Pharmaceu, 9; C. Malattia, None.

To cite this abstract in AMA style:

van Dijkhuizen P, Covizzi C, Schiappacasse A, Moraldo M, Santoro M, Magnaguagno F, Magnano G, Martini A, Malattia C. New Prospects for Interpreting Bony Depressions in Juvenile Idiopathic Arthritis: A Novel MRI Computer-Assisted Technique for Detection of Erosive Progression [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/new-prospects-for-interpreting-bony-depressions-in-juvenile-idiopathic-arthritis-a-novel-mri-computer-assisted-technique-for-detection-of-erosive-progression/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/new-prospects-for-interpreting-bony-depressions-in-juvenile-idiopathic-arthritis-a-novel-mri-computer-assisted-technique-for-detection-of-erosive-progression/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology